A detailed history of Cubist Systematic Strategies, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 53,494 shares of STIM stock, worth $93,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,494
Holding current value
$93,614
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.68 - $4.8 $143,363 - $256,771
53,494 New
53,494 $254,000
Q1 2023

May 15, 2023

BUY
$2.81 - $6.71 $160,923 - $384,268
57,268 Added 222.65%
82,989 $241,000
Q4 2022

Feb 14, 2023

BUY
$3.44 - $6.87 $37,530 - $74,951
10,910 Added 73.66%
25,721 $176,000
Q3 2022

Nov 14, 2022

SELL
$2.35 - $4.66 $709 - $1,407
-302 Reduced 2.0%
14,811 $47,000
Q2 2022

Aug 15, 2022

BUY
$2.09 - $3.71 $9,760 - $17,325
4,670 Added 44.72%
15,113 $49,000
Q1 2022

May 16, 2022

BUY
$2.84 - $4.52 $29,658 - $47,202
10,443 New
10,443 $32,000
Q4 2021

Feb 14, 2022

SELL
$3.87 - $6.59 $206,623 - $351,846
-53,391 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$6.22 - $15.54 $332,092 - $829,696
53,391 New
53,391 $350,000
Q2 2021

Aug 16, 2021

SELL
$10.15 - $17.25 $191,916 - $326,163
-18,908 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$10.6 - $21.27 $200,424 - $402,173
18,908 New
18,908 $234,000
Q1 2019

May 15, 2019

SELL
$13.6 - $19.58 $78,784 - $113,426
-5,793 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$16.0 - $31.84 $60,608 - $120,609
3,788 Added 188.93%
5,793 $112,000
Q3 2018

Nov 14, 2018

BUY
$24.32 - $37.54 $19,577 - $30,219
805 Added 67.08%
2,005 $64,000
Q2 2018

Aug 14, 2018

BUY
$26.61 - $27.78 $31,932 - $33,336
1,200 New
1,200 $32,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $47.3M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.